A ‘Lame Duck’ Feast: December Could Be Busy For Pharma On Capitol Hill

An agreement to extend government funding until 20 December means no shutdown for the US FDA or other agencies, but also that a busy December awaits for biopharma lobbyists.

lame duck
Several pharma industry-related bills could find a vehicle to enactment during Congress' December "lame duck" session. • Source: Shutterstock

More from Legislation

More from Pink Sheet